Claim compensation in the Avandia drug Canada-wide settlement
HALIFAX, Nov. 15, 2019 /CNW/ - The Avandia drug class action lawsuit has reached a Canada-wide settlement, Wagners announced today.
The settlement applies to Canadians who were prescribed and ingested the drug Avandia and, if that person is deceased, to their spouse, children, grandchildren, parents, grandparents and siblings (together "Class Members"). Class Members must satisfy eligibility criteria, and not all Class Members will be eligible for compensation.
Compensation under the settlement is available for Class Members who used Avandia for at least thirty continuous days commencing before December 2010 and who suffered one of the following injuries within no more than one year of such use: a heart attack, congestive heart failure, coronary artery bypass graft (CABG), and/ or coronary intervention stent placement. Other eligibility considerations described in the Settlement Agreement will affect how much compensation a Class Member will receive.
Class Members can apply now at www.avandiaclassaction.ca. Claim forms and supporting documentation must be submitted by July 15, 2020.
Women's Heart Health Month is recognized every May and is focused on raising awareness about cardiovascular health among women. It aims to educate women about the risks, symptoms, and prevention of heart disease, which is the leading cause of death...
RaySearch Laboratories AB (publ) and C-RAD are pleased to announce a collaboration agreement, aiming at jointly developing innovative solutions and products to enhance the quality of radiation therapy.
The focus of the collaboration is to...
SecondOpinionExpert, Inc. (SOE), a leading healthcare technology company, announced today that OC Fertility® + OC Biogenix® located in Newport Beach, Orange County, California will join SOE's expert panel to provide second opinions for fertility...
Scientology Network's VOICES FOR HUMANITY, the weekly series presenting heroic change makers from a variety of faiths, cultures and nations, working to uplift their communities, announces a new episode featuring anti-drug activist Robert Galibert....
Chemistree Technology Inc. and (US OTC: CHMJF) (the "Company" or "Chemistree"), announces that its board of directors (the "Board") has approved a restructuring transaction (the "Restructuring Transaction"), pursuant to which all of the principal of...
